← Open Payments lookup

DANIELLE HAMILL: Open Payments

NPI 1679973119 · BLACKFOOT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$986 in 50 payments from 11 companies in 2025. Trend: 2023 $330 · 2024 $495 · 2025 $986

Food & beverage: $986
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.16$236
Otsuka America Pharmaceutical, Inc.7$156
Vanda Pharmaceuticals Inc.5$124
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$110
Alkermes, Inc.4$77
ABBVIE INC.4$74
Neurocrine BioSciences, Inc.3$63
Axsome Therapeutics, Inc.2$53
E.R. Squibb & Sons, L.L.C.3$51
Takeda Pharmaceuticals U.S.A., Inc.1$21

Products named: AUSTEDO XR, FANAPT, CAPLYTA, UZEDY, ABILIFY ASIMTUFII, VRAYLAR, REXULTI, INGREZZA.

Industry payments across ID — which companies pay providers there.